✦ LIBER ✦

LONG TERM ENDOTHELIN RECEPTOR ANTAGONIST IMPROVES CORONARY ENDOTHELIAL FUNCTION IN PATIENTS WITH EARLY ATHEROSCLEROSIS

✍ Scribed by Martin, Reriani Kaiga; Raichlin, Eugenia; Prasad, Abhiram; Mathew, Verghese; Lennon, Ryan; Rihal, Charanjit; Lerman, Lilach; Lerman, Amir

Book ID: 122221417
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 74 KB
Volume: 55
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(10)61481-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term endothelin receptor antagonism

Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis

✍ Yoon, Myeong Ho; Reriani, Martin; Mario, Gössl; Rihal, Charanjit; Gulati, Rajiv; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Angiotensin receptor antagonist losartan

Angiotensin receptor antagonist losartan improves endothelial function of epicardial coronary arteries in patients with essential hypertension

✍ You-Bin Deng; Hao-Yi Yang; Chun-Lei Li; Qing Chang 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Improvement of vascular endothelial func

Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis

✍ P. P. Sfikakis; C. Papamichael; K. S. Stamatelopoulos; D. Tousoulis; K. G. Fragi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Objective Increased endothelin activity may play a role in the pathogenesis of vascular injury, a primary feature of systemic sclerosis (SSc; scleroderma). Our goal was to test the hypothesis that treatment with the oral endothelin receptor antagonist bosentan might improve vascular

Improved endothelial function after endo

Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis

✍ Carmine Cardillo; Francesca Schinzari; Domenico Melina; Nadia Mores; Silvia Bose 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

The endothelin receptor antagonist bosen

The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial

✍ A. Rafnsson; F. Böhm; M. Settergren; A. Gonon; K. Brismar; J. Pernow 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 214 KB

Daily administration of the TP receptor

Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis

✍ Pierre-François Lesault; Laurent Boyer; Gabriel Pelle; Ala Covali-Noroc; Dominiq 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 952 KB